west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "刘维永" 15 results
  • Progress in Early Diagnosis and Treatment of Severe Heart and Great Vessel Injury

    Severe heart and great vessel injuries were a fatal traumatic entity. How to improve the survival rate of these victims still was a challenge to date. This paper included: the pathogenesis and resuscitation of commotio eordis ; traumatic pericardial rupture associated with heart luxation and/or diaphragmatocele in pericardial cavity; indication selection of emergency room thoracotomy for severe heart injury and traumatic aortic disruption treated with endovascular stent graft. For the purpose of increasing our recognition of the severe trauma and making the early diagnosis and management as early as possible. The main relative references published in recently 5 years were reviewed.

    Release date:2016-08-30 06:22 Export PDF Favorites Scan
  • 胸主动脉瘤及主动脉夹层外科治疗进展

    胸主动脉瘤及主动脉夹层病情凶险,死亡率和病残率均很高.近几年在保留和不保留主动脉瓣的主动脉根重建术治疗升主动脉瘤,弓部主动脉瘤切除与脑保护,胸主动脉瘤或胸腹主动脉瘤切除与脊髓保护,以及主动脉腔内支架移植术等方面取得了较大的进展.手术死亡率已从31.4%下降至3.3%~4.8%.胸主动脉瘤,特别是主动脉夹层系一全身性主动脉病变,近年来手术疗效有所改善,但远期复发率和再手术率仍较高.主动脉内支架移植与外科手术结合应用,对复杂的伴有降主动脉病变的A型主动脉夹层治疗,可能是一种安全而有效的方法.

    Release date:2016-08-30 06:30 Export PDF Favorites Scan
  • 加强现代临床医学研究,规范术前风险评估

    心脏瓣膜病是一组常见的心血管病,在诊治技术上临床医师已积累了丰富经验,患者寿命和生活质量均获得明显提高。2007年欧洲心脏病学会(ESC)提出了欧洲心脏手术风险评估系统(European System for Cardiac Operation Risk Evaluation, EuroSCORE),2008年美国心脏病学院/美国心脏协会(ACC/AHA)对心脏瓣膜病治疗指南进一步作了修正,国内也开始了相关研究,对临床工作有着重要指导和借鉴作用。上海第二军医大学长海医院撰写的“心脏瓣膜手术在院死亡风险预测模型及评分标准的建立”论文,收集了该院1998年1月1日至2008年12月31日11年间4 032例各类心脏瓣膜手术患者的临床资料,参照国内外相关文献并以在院死亡为研究终点指标,通过自行研发的心脏瓣膜外科数据库,纳入了48个影响死亡的潜在危险因素,首先进行单因素分析,然后采用逐步logistic回归分析方法,建立了心脏瓣膜手术在院死亡风险预测模型。该文分成两个亚库,建模亚库(2 418/4 032,60%)和验证亚库(1 614/4 032,40%),进行对比观察,提示无论在预测的校准度,还是在鉴别效度方面都比较好,均能较准确地预测心脏瓣膜手术在院病死率;并根据已建立的风险预测模型中各危险因素的权衡系数β,及其变量类型构建了风险预测的评分标准。 研究结果表明:慢性肺部疾病、心功能分级(NYHA)Ⅲ~Ⅳ级、左心室射血分数(LVEF)低下、血清肌酐异常、术前危重状态、同期施行冠状动脉旁路移植术(CABG)、三尖瓣关闭不全和主动脉瓣狭窄,均为心脏瓣膜手术在院死亡的独立危险因子,与国外研究结果大致相同。讨论中作者指出未发现与高龄相关。然而必须指出的是人口老龄化,老年重症瓣膜病,特别是主动脉瓣钙化手术必将逐年上升,据2000年前国外对大组心瓣膜置换术病例统计,小于70岁患者手术病死率为3.66%,70~80岁者为6.07%,80~90岁者为7.53%,大于90岁者为11.14%。因而提出对80岁以上心脏瓣膜病患者应严格掌握手术适应证,对丧失活动能力、神经精神障碍严重、心功能不全,特别是全身多器官功能衰竭患者应视为手术禁忌证,这是我国当前尚未完全遇上的问题,将来必然要面对。文中提出血清肌酐水平异常是独立危险因子,而肾功能衰竭反而不是。因前者正是肾功能不全的1个指标,肾功能衰竭应放在肾功能不全一组中,才不致出现统计学处理时像该文表2“心脏瓣膜手术在院死亡的潜在危险因素及其单因素分析”中二者对立现象;此外,全组仅1例肾功能衰竭,还是生存患者,作为独立因素对待,也不符合统计学要求,这可能是导致上述矛盾现象的原因。该研究发现三尖瓣关闭不全和主动脉瓣狭窄是手术在院死亡的独立危险因子,作者在讨论中提出国外文献中未见报道,并指出肺动脉高压与三尖瓣关闭不全2个变量间存在较大关联性。 因为影响心脏瓣膜手术风险的因素是多方面的,而且往往又相互交叉影响,所以对具体患者和具体情况应具体分析。近10年来心脏瓣膜手术方式有了很大的发展,开展了对二尖瓣脱垂导致的关闭不全经缘对缘缝合的介入手术,全腔镜下和机器人下施行二尖瓣手术,以及对高龄危重主动脉瓣患者经导管或微创支架瓣膜置换术等。据2010年美国经导管心血管治疗(Transcatheter Cardiovascular Therapeutis,TCT)国际会议资料报道,后者全球已超过2万病例,对这类新型手术在院死亡风险因素的判断标准,自然和本文常规心脏瓣膜手术应有区别或不尽相同。“心脏瓣膜手术在院死亡风险预测模型及评分标准的建立”一文紧紧把握了我国心脏瓣膜外科领域当前临床研究的重要方向,研究目标明确,样本量大,内容丰富,设计合理,结论可信,是一件很有意义的事,具有较高的学术价值和社会效益。该文虽属单中心研究,但符合中国国情,对临床工作有指导意义,值得推广,并希望在工作中不断完善,最终能进一步形成多中心乃至达成全国共识的常规心脏瓣膜手术风险预测模型及评分标准,以规范术前风险评估工作。它对进一步降低我国心脏瓣膜手术在院病死率和加强国际交流,必将起到积极的作用。收稿日期:2011-01-14编辑 冯远景

    Release date: Export PDF Favorites Scan
  • Review and Prospect of Total Cavopulmonary Connection

    Fontan operation is still a main procedure for treatment of complex congenital heart disease, such as univentricular heart. Fontan procedure has undergone many revisions since its introduction in 1968. The earlyapplied atriumpulmonary connection has been replaced by total cavopulmonary connection. The midterm and late results of both the intraatrial lateral tunnel and extracardiac total cavopulmonary connections were compared and analyzed in this article. Extracardiac conduit is better. The Fontan circulation failure would appear at last because of nopump function of the right ventricle. Once Fontan circulation failure occurred and could not recover by medicine, heart transplantation is mandatory, but the source of donor heart is lacking. The study of mechanical cavopulmonary assist device, to “biventricularize” the univentricular Fontan circulation, has been developed, which is quite promising. Following the development of diagnostic and treatment techniques for fetal heart disease, the treatment procedure of complex congenital heart disease has been broadened in recent years, such as to prevent the severe aortic stenosis from developing into hypoplastic left heart syndrome with fetal cardiac intervention so as to increase the chance of biventricular repair, and to terminate gestation to decrease its birth rate of complex heart abnormalities, which could not be completely repaired to date.

    Release date:2016-08-30 05:56 Export PDF Favorites Scan
  • Acellular Tissue Engineering Heart Valve

    The study of tissue engineering heart valves is one of the focus about cardiovascular surgery and is developing. Especially acellular tissue engineering heart valves have many advantages in low immunogenicity,non cytotoxicity,recellularation,excellent bionics,durability etc.Therefore, the study of acellular tissue engineering heart valves is becoming the important direction of future development about valves studies. Some development about it is reviewed.

    Release date:2016-08-30 06:24 Export PDF Favorites Scan
  • 组织工程心脏瓣膜构建现状与发展

    摘要 为了克服目前临床应用的人工心脏瓣膜在抗凝和衰坏方面的缺点,随着组织工程学的发展,构建组织工程心脏瓣膜的研究已取得初步进展。综述近年来组织工程心脏瓣膜在种植材料、种子细胞、动物实验和基础研究方面取得的进展,并探讨组织工程心脏瓣膜的优越性和可行性。

    Release date:2016-08-30 06:33 Export PDF Favorites Scan
  • 生物瓣心瓣膜置换术后远期疗效

    目的评价生物瓣心瓣膜置换术后远期疗效。方法1979年1月至2001年12月施行生物瓣心瓣膜置换术303例,按年龄分为两组,≥55岁者123例(≥55岁组);(55岁者180例(〈55岁组)。其中160例早期使用经戊二醛处理的猪主动脉瓣,143例使用经环氧氯丙烷改性的新型猪主动脉瓣。所有心瓣膜置换术均在全身麻醉体外循环下进行。结果术后早期死亡9例,随访267例(90.8%),随访时间3~20年,5年生存率94.1%±2.3%,10年生存率85.0%±2.7%,15年生存率78.3%±1.2%。51例出现瓣膜衰坏,40例再次手术;5年、10年、15年累计瓣膜未衰坏率分别为90.1%±2.2%、79.4%±3.6%和36.8%±1.6%。且≥55岁组患者瓣膜未衰坏率高于(55岁组(P〈0.05)。经环氧氯丙烷改性的新型生物瓣10年瓣膜未衰坏率明显高于早期戊二醛处理的生物瓣。全组血栓发生率低,15年为0.014%。发生感染性心内膜炎7例,3例治愈,4例死亡。结论人工生物瓣心瓣膜置换术后疗效良好,尤其适合老年患者。经环氧氯丙烷改性的新型生物瓣有较强的抗衰坏能力;术后发生感染性心内膜炎应予以足够的重视。

    Release date:2016-08-30 06:22 Export PDF Favorites Scan
  • Primary Investigation of Degradation Behavior of Acellular Porcine Aortic Valve in Vitro

    Objective To investigate the way and process of degradation behavior of acellular porcine aortic valve in vitro. Methods Acellular porcine aortic valve(n=90)were randomly divided into 3 groups (collagenase group, elastase group, control group), 30 piece in each group . Behavior of acellular porcine aortic valve was degradated with 0.05mg/ml collagenase Ⅰ, 0. 05mg/ml elastase, phosphate buffered solution in collagenase group, elastase group and control group. The histomorphology, weight loss, value of protein and hydroxyproline were observed at 3,6,9, 12, 15 and 30d after degradation. Results The behavior of acellular porcine aortic valve of collagenase group and elastase group became poorer, looser and broken gradually in degradation. The weight loss of valve, the value of protein and hydroxyproline in vehiculum became greater gradually in collagenase group and elastase group(P〈0. 01). Furthermore the effect of collagenase Ⅰ was b than elastase in degradation. Conclusion The effect of collagenase Ⅰ and elastase can degradate the acellular porcine aortic valve in vitro. Collagenase Ⅰ is b than elastase in degradation.

    Release date:2016-08-30 06:23 Export PDF Favorites Scan
  • Preliminary Study on the Biological and Biomechanicai Characteristics of Deceilularized Bovine Jugular Venous Tissue-engineered Valved Conduits

    Objective To compare the biological and biomechanical characteristics of decellularized bovine jugular venous tissue-engineered valved conduit scaffolds with that of fresh bovine jugular veins. Methods Fortyeight fresh bovine jugular veins were divided into control group and experimental group with random number table method, 24 veins in each group. There were fresh bovine jugular veins in control group, decellularized bovine jugular veins in experimental group. The veins of experimental group were treated with sodium deoxyeholate plus Triton-X-100 to decellularize the cells in valves and vessel walls. The thickness, water absorption rate, water maintenance rate, destroying strength, stretch rate of valves and vessel walls in two groups were detected. Results The endothelial cell and fibroblast of valves and vessel walls in experimental group were completely decellularized, no cell fragments were retained within the matrix scaffold; collagen fiber and elastin fiber had been preserved with intact structure and wavily arrayed; deoxyribonucleic acid content of valves and vessel walls in experimental group were decreased by 97.58%, 97.25% compared with that of control group. The thickness, water absorption rate and water maintenance rate of valves and vessel walls in experimental group were lightly increased than those of control group, but there were no significant differences between them (P 〉 0. 05). There were no significant differences in destroying strength and stretch rate of valves and vessel walls between two groups (P〉0. 05). Conclusion Decellularized bovine jugular vein scaffold has stable biological and biomechanical characteristics and it may be ideal natural fibrous matrix for developing the tissue-engineered valved conduit by host recellularization.

    Release date:2016-08-30 06:26 Export PDF Favorites Scan
  • 同种原位心脏移植四例

    目的 总结4例终末期心脏病患者施行原位心脏移植术的经验. 方法 2000年1月26日~2000年9月26日,先后对4例终末期心脏病患者施行原位心脏移植术.供者均为脑死亡者,供者心肌保护采用冷晶体心脏停搏液顺行性灌注;手术方法为中度低温体外循环下标准原位心脏移植术;术后采用新三联(FK506、骁悉和强的松)免疫治疗. 结果 1例因肝、肾功能衰竭,术后18天死亡.3例患者存活至今,且生活质量良好. 结论 掌握适应证、术后防治感染和合理的免疫治疗,是提高心脏移植存活率的重要因素.

    Release date:2016-08-30 06:30 Export PDF Favorites Scan
2 pages Previous 1 2 Next

Format

Content